[Retroperitoneal recurrence of non-seminomatous testicular tumors: computerized tomography findings before retroperitoneal lymph node excision]
- PMID: 10071646
- DOI: 10.1055/s-2007-1011008
[Retroperitoneal recurrence of non-seminomatous testicular tumors: computerized tomography findings before retroperitoneal lymph node excision]
Abstract
Purpose: In relapsing testicular cancer, additional chemotherapy is followed by abdominal CT. If residual lesions are found, retroperitoneal lymphadenectomy is considered. We studied retrospectively whether morphological criteria can help in selected cases in deciding about lymphadenectomy by distinguishing between vital tumor, scarring and mature teratoma.
Methods: In 26 patients who had been treated by salvage chemotherapy and retroperitoneal lymphadenectomy for non-seminomatous testicular cancer between 1990 and 1997, abdominal computed tomography and histology were correlated.
Results: Histological examination found scarring in 10 patients, vital tumor in 6, mature teratoma in 4, and simultaneous teratoma and vital tumor in 6. A single CT criterion for distinguishing between these histologies was not identified. In two patients with large masses which were partly cystic and partly solid vital tumor and teratoma were verified. Scarrings may be expected in cystic lesions at the level of the renal hilus which are lined by a thin and smooth wall. Size did not matter.
Conclusion: Accurate differentiation between vital tumor and necrosis was not possible. Before lymphadenectomy CT, however, localised lesions.
Similar articles
-
[Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].Urologe A. 1998 Nov;37(6):609-20. doi: 10.1007/s001200050223. Urologe A. 1998. PMID: 9887489 German.
-
Craniocaudal retroperitoneal node length as a risk factor for relapse from clinical stage I testicular germ cell tumor.AJR Am J Roentgenol. 2014 Oct;203(4):W415-20. doi: 10.2214/AJR.13.11615. AJR Am J Roentgenol. 2014. PMID: 25247970
-
Reoperative retroperitoneal lymph node dissection for metastatic germ cell tumors: analysis of local recurrence and predictors of survival.J Urol. 2014 Jun;191(6):1777-82. doi: 10.1016/j.juro.2014.01.010. Epub 2014 Feb 8. J Urol. 2014. PMID: 24518787
-
[Urologic treatment of testicular germ cell cancer].Arch Esp Urol. 2002 Oct;55(8):927-36. Arch Esp Urol. 2002. PMID: 12455283 Review. Spanish.
-
Retroperitoneal lymph node dissection after chemotherapy.BJU Int. 2009 Nov;104(9 Pt B):1404-12. doi: 10.1111/j.1464-410X.2009.08867.x. BJU Int. 2009. PMID: 19840021 Review.
Cited by
-
The role of [(18)F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management.World J Urol. 2004 Jun;22(2):132-9. doi: 10.1007/s00345-003-0392-6. Epub 2004 Jan 21. World J Urol. 2004. PMID: 14735310
-
[Positron emission tomography (PET) for diagnosis and monitoring of treatment for urological tumors].Urologe A. 2004 Nov;43(11):1397-409. doi: 10.1007/s00120-004-0714-3. Urologe A. 2004. PMID: 15502907 German.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical